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Abstract
Objective National guidelines advocate referring patients with persistent synovitis to rheumatology
within 3 working days of presentation to primary care. This occurs infrequently. We aimed to identify
modifiable barriers to early referral of suspected RA patients among English general practitioners
(GPs).
Methods We carried out a national cross-sectional survey of 1388 English GPs (RA Questionnaire
for GPs [RA-QUEST] study). Questions addressed GPs’ confidence in diagnosing RA, clinical factors
influencing RA diagnosis/referral, timeliness of referrals and secondary care access. Data were cap-
tured using 10-point visual analog scales, five-point Likert scales, yes/no questions or free text, and
were analysed descriptively.
Results Small joint swelling and pain were most influential in diagnosing RA (91 and 84% rated the
importance of these as 4 or 5 on a five-point Likert scale, respectively); investigations including RF
(61% rating 4 or 5) and anti-CCP antibody (72% rating 4 or 5) were less influential. Patient history had
the greatest impact on the decision to refer (92% rating this 4 or 5 on a 5-point Likert scale), with
acute phase markers (74% rating 4 or 5) and serology (76% rating 4 or 5) less impactful. Despite the
importance placed on history and examination, only 26% referred suspected RA immediately without
investigations; 95% of GPs organizing further tests opted to test for RF.
Conclusion For suspected RA patients to be referred within 3 days of presentation to primary care
there needs to be a paradigm shift in GPs’ approaches to making referral decisions, with a focus on
clinical history and examination findings, and not the use of investigations such as RF.
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Key messages
. Most general practitioners organize tests before deciding to refer suspected RA patients.
. An over-reliance is placed on RF testing when making referral decisions for suspected RA.
. A change in referral practice is required, making decisions based on clinical findings.
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Introduction
The early diagnosis and prompt treatment of RA by spe-
cialists improves patient outcomes [1]. In England, the
National Institute for Health and Care Excellence (NICE)
Quality Standards for RA recommend that patients with
persistent synovitis are referred to a rheumatology ser-
vice within 3 working days of presentation to primary
care [2]. The British Society for Rheumatology
Healthcare Quality Improvement Partnership national
audits based on these quality standards highlighted the
challenges in achieving them [3], with only 17 and 20%
of patients referred within 3 working days, in the first
and second audits, respectively. Similar referral delays
from primary to secondary care exist in other European
countries [4] and North America [5].
Several factors contribute to these referral delays.
Firstly, the rarity of RA (annual incidence 15/100 000
adults [3]) means that non-specialists lack experience in
recognizing it. Secondly, the heterogeneous nature of
early RA can make identifying it challenging [6, 7].
Thirdly, general practitioners (GPs) traditionally make di-
agnoses before referral, using investigations to support
their clinical opinion; requesting tests in patients with
suspected RA will invariably delay the referral process.
Variations in national health-care structures mean that
factors contributing to referral delays need to be considered
on a country-specific basis. Data on factors associated with
GP referral delays of suspected RA in England are limited,
but existing studies suggest that referral decisions are
strongly influenced by test results (chiefly RF and radio-
graphs), with negative/normal tests making referral less likely
or timely [8–10]. These studies are limited by their regional
nature [10], small size [8] or focus on a single factor [9].
To increase the proportion of RA referrals meeting the
NICE quality standard time line (3 working days) a range
of modifiable barriers to early referral need to be identi-
fied, which have generalizable impacts across England.
The RA Questionnaire for GPs (RA-QUEST) study was
designed to achieve this. It is a large, prospective sur-
vey of 1388 English GPs’ experiences in diagnosing and
referring suspected RA patients to secondary care.
Methods
National GP survey
Five thousand English GPs, randomly selected using
Binley’s database (National database of GP practice con-
tact details) [11], were mailed a questionnaire in 2014,
asking 12 questions about challenges in diagnosing and
referring suspected RA patients, alongside questions
about their demographics and primary care practice.
Questionnaire development
The questionnaire was developed by a focus group of
clinical and academic GPs, and rheumatologists at
Keele University; it was subsequently piloted and refined
with local GPs before national implementation. Question
items were sought to cover GP access to rheumatology,
knowledge of RA symptoms/signs, confidence in diag-
nosing RA and which factors influence the decision to
refer and time scale of referral.
Questions about challenges in diagnosing and
referring suspected RA
The 12 questions about diagnosing and referring patients
with suspected RA are provided in supplementary Table
S1 and Fig. S1, available at Rheumatology Advances in
Practice online. In brief, they evaluated GP confidence in
diagnosing RA and recognizing synovitis; how many
patients GPs suspected they had seen with new-onset
RA in the previous 2 years; what GPs felt were the most
important symptoms in diagnosing RA (with the symp-
toms listed being derived from a previous qualitative study
of symptom complexes during the earliest phases of RA
[7]); if they had heard of the S-factor campaign (an
Arthritis Research UK/National RA Society delivered cam-
paign promoting the need for patients to consult their GP
early for symptoms of RA [12]) and its impact on their
practice; what they felt were the most important features
in making a decision to refer a patient with suspected RA;
whether they referred patients with suspected RA immedi-
ately or requested further tests first; their access to sec-
ondary care rheumatology; and what they felt were the
challenges in making an RA diagnosis. These questions
were completed using a mixture of: (i) 10-point visual ana-
log scales (VAS), for example, ‘How confident are you at
diagnosing RA?’ on a scale of 0 (not at all confident) to
10 (completely confident); (ii) yes/no responses, for exam-
ple, ‘Do you have access to a dedicated early arthritis
clinic?’; (iii) five-point Likert scales; or (iv) free-text boxes.
Statistical analysis
All data were summarized descriptively, using mean
(S.D.), median [interquartile range (IQR)] and number (per-
centage) where appropriate based on data type, and
distributions. The associations between GP time since
qualification and gender, and confidence in diagnosing
RA and referral practice, were evaluated using linear
and logistic regression models. Missing data were omit-
ted from the analysis (supplementary Table S2, available
at Rheumatology Advances in Practice online).
Ethical approval
The study was approved by the Keele University Ethics
Review Panel. As it represented an anonymous study of
primary care practitioners, national ethical committee
approval was not required. Written informed consent
was obtained from participating practitioners.
Results
General practitioner characteristics
One thousand three hundred and eighty-eight com-
pleted questionnaires were returned (28% response
rate). Most GPs were partners (845; 61%), with salaried
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(291; 21%), senior partner (207; 15%) and locum (36;
3%) GPs being less common. Their mean age was 47
years, mean time since qualification was 23 years, and
705 (51%) were male. Only 38 GPs (3%) had heard of
the S-factor campaign. Of those completing the free-text
response regarding its impact on their clinical practice,
the commonest responses were that it helped in identify-
ing patients with RA (nine GPs; 24%), increased aware-
ness of RA (four GPs; 11%), meant they were more likely
to refer suspected RA patients early (three GPs; 8%) or
had no impact (nine GPs; 24%). A bar-plot outlining
these responses is given in supplementary Fig. S2, avail-
able at Rheumatology Advances in Practice online. The
median (IQR) score for the number of patients with sus-
pected RA seen over the preceding 2 years was 4 (2–6).
Access to rheumatology
Four hundred and ninety-eight (38%) GPs had access to
dedicated early arthritis clinics. The median (IQR) VAS
rating for ease of access to secondary care rheumatol-
ogy was 7 (5–8), indicating that most GPs considered
they had moderate ease of access (Fig. 1). General
practitioners reporting access to dedicated early arthritis
clinics had a higher median (IQR) VAS (7; 6–8) for ease
of access to rheumatology compared with those report-
ing no access to early arthritis clinics (6; 5–8).
Challenges in diagnosing RA
Key clinical features
Of the 24 clinical features provided, GPs identified the
following five as the most important in diagnosing RA
(Fig. 2): small joint swelling (91% rated this 4 or 5 for
importance, out of a possible 5), small joint pain (84%
rated this 4 or 5 for importance), raised ESR/CRP (82%
rated this 4 or 5 for importance), early morning stiffness
>60 min (80% rated this 4 or 5 for importance) and
symmetrical joint swelling (78% rated this 4 or 5 for im-
portance). Median (IQR) Likert scores were 4 (4–5) for all
five features.
Likert scores for other features included in RA classifi-
cation criteria [13, 14] were considered less diagnosti-
cally important: positive anti-CCP (72% rated this 4 or 5
for importance), any joint swelling (64% rated this 4 or 5
for importance), positive RF (61% rated this 4 or 5 for
importance) and radiographic changes consistent with
RA (57% rated this 4 or 5 for importance). Median (IQR)
Likert scores were 4 (3–5) for anti-CCP and 4 (3–4) for
the other clinical features.
Confidence
General practitioners were moderately confident at diag-
nosing RA and detecting synovitis, with median self-
rated VAS of 7 (5–7) and 7 (6–8) out of 10, respectively
(Fig. 1).
Key challenges
The main perceived challenges in diagnosing RA were
‘the earliest phases of RA are difficult to recognize’, and
‘RA can be difficult to distinguish from other potential di-
agnoses’, with 80 and 82% strongly/moderately agree-
ing with these statements, respectively (Fig. 2). Despite
often requesting RF before making a decision to refer,
48% strongly/moderately agreed with the statement
‘Information provided by RF testing does not aid my
clinical decisions’. Two hundred and forty-four GPs pro-
vided free-text information in response to question 12
FIG. 1 Confidence in diagnosing RA (A) and detecting synovitis (B), and ease of access to rheumatology (C)
(A) General practitioner (GP) confidence on Visual Analogue Scale (0¼not at all confident; 10¼completely confident)
in diagnosing RA. (B) GP confidence on Visual Analogue Scale (0¼not at all confident; 10¼completely confident) in
recognizing synovitis. (C) GP rating ‘How easy is it for you to access secondary care rheumatology?’ on a visual ana-
log scale (0¼very difficult; 10¼very easy).
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(addressing the challenges faced by GPs in diagnosing
RA), with the main challenge being a perceived delay in
access to secondary care services (reported by 98 GPs;
40.2%; supplementary Fig. S2, available at Rheumatol-
ogy Advances in Practice online).
Referral decisions
Factors influencing referrals
General practitioners rated patient history as the most
important clinical feature in making a decision to refer,
with 92% rating this 4 or 5 [median (IQR) score 5; 4–5]
out of a possible 5 (supplementary Fig. S3, available at
Rheumatology Advances in Practice online). Similar
Likert scores were obtained for clinical examination
[81% rating 4 or 5; median (IQR) score 4; 4–5], RF/anti-
CCP serology [76% rating 4 or 5; median (IQR) score 4;
4–5] and raised ESR/CRP [74% rating 4 or 5; median
(IQR) score 4; 3–5]. Little weight was placed on family
history of RA [39% rating 4 or 5; median (IQR) score 3;
3–4]. Seventy-eight GPs provided free-text information
on additional factors they felt important in making a de-
cision to refer a patient (supplementary Fig. S2, available
at Rheumatology Advances in Practice online), with the
FIG. 2 GP responses to Likert scale questions on the important clinical features (A) and perceived challenges (B) in
diagnosing RA.
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commonest responses being X-rays (14 GPs; 17.9%),
disability (seven GPs; 9%), persistent or severe symp-
toms (seven GPs; 9%), stiffness (seven GPs; 9%) and
synovitis (seven GPs; 9%).
Referral timeliness
Only 343 (26%) GPs would refer suspected RA immedi-
ately to secondary care; 999 (74%) preferred to organize
further tests to inform referral decisions. Of the GPs
who would organize further tests, the most frequently
requested were RF (944 GPs; 95%), CRP (932 GPs;
93%) and ESR (883 GPs; 88%). Radiographs (544 GPs;
55%) and anti-CCP antibody testing (433 GPs; 43%)
were less commonly used, and joint US (32 GPs; 3%)
was used rarely. One hundred and sixty GPs provided
free-text information on additional tests they would use
(supplementary Fig. S2, available at Rheumatology
Advances in Practice online), with the commonest being
a list of multiple different blood tests (many of which in-
cluded ANA and uric acid; 75 GPs; 46.9%), ANA and
other autoantibodies (19 GPs; 11.9%) and full blood
count tests (17 GPs; 10.6%).
Associations between GP demographics, confidence
and referral practice
General practitioner time since qualification
In a linear regression model, which included confidence
in diagnosing RA (on a 10-point VAS) as the response
variable and time since qualification (in years) as the ex-
planatory variable, a significant association was ob-
served (P¼ 0.01), suggesting that GP confidence at
diagnosing RA increases as more clinical experience is
accrued. The effect was, however, small, with a b-value
of 0.01, indicating that per 10-year increase in the time
since qualification, the confidence in diagnosing RA VAS
increased by merely 0.10 (out of a possible 10 units).
In a logistic regression model including the binary an-
swer to the question, ‘If you suspect RA clinically do
you refer immediately or arrange further tests first?’ as
the response variable and time since qualification as the
explanatory variable, no association was seen (P¼0.62).
General practitioner gender
Undertaking the same modelling approach but including
GP gender as the explanatory variable (in place of time
since qualification), an association was observed be-
tween gender and reported confidence in diagnosing RA
(P<0.01) but not referral practice (P¼ 0.49). Female
GPs appeared to be more confident at diagnosing RA.
The b-value of 0.45 obtained from the linear regression
model indicated that females had a 0.45 higher VAS for
confidence in diagnosing RA than males.
Discussion
Our national survey of English GPs found that when they
suspect a patient has RA, the majority (74%) request
investigations to support their clinical opinion before re-
ferral. Consequently, most GPs cannot meet the NICE
quality standard of referring patients with persistent sy-
novitis within 3 days. Meeting this quality standard
requires a paradigm shift in the primary care approach
to inflammatory arthritis referrals, with patients present-
ing with synovitis being referred on clinical grounds
without waiting for the results of investigations. As our
survey showed that GPs have a good knowledge of the
clinical features of RA (with most correctly identifying
small joint swelling, pain, early morning stiffness and
symmetrical joint swelling as the most important symp-
toms/signs) this change in practice should be
achievable.
We found an over-reliance on RF testing in primary
care, undertaken by 95% of those GPs requesting tests
before referral. Although we did not capture information
on whether RF status influences final referral decisions,
two previous English studies reported that RF-negative
patients were less likely to be referred [10] or were re-
ferred significantly later [9]. Another study of 36 191 RF
requests made to one English laboratory between 2003
and 2009, at an annual cost of £58 164, found that the
majority (67%) originated from primary care, with only
7% made by rheumatologists [15]. The rate of positive
results in primary care was low, at 6%, compared with
18% for rheumatologists. When these findings are con-
sidered against NICE recommendations, there is an
argument for restricting the use of RF testing to rheuma-
tology units.
Another major source of delay in suspected RA
patients being seen lies with secondary care services
failing to see primary care referrals promptly. Our study
suggests that this is an ongoing issue, with 62% of GPs
reporting no access to early arthritis clinics, and 25%
rating their ease of access to rheumatology as being 5
out of 10. The need to minimize secondary care delay is
also addressed in the NICE RA Quality Standards, which
recommend that people with suspected persistent syno-
vitis are assessed in a rheumatology service within 3
weeks of referral. The British Society for Rheumatology
Healthcare Quality Improvement Partnership audit
reported that the presence of early inflammatory arthritis
clinics increased the odds of meeting this standard by
60% (OR ¼ 1.6; 95% CI: 1.4, 1.7; P< 0.001). This sug-
gests that changes in primary care referral practice
need to be linked with an increased provision of early in-
flammatory arthritis clinics.
Our study’s strength is that it represents a large na-
tional survey, with GP practices randomly selected. Its
limitation is the modest response rate (28%). Our re-
sponse rate is, however, similar to other recent national
UK surveys [16, 17], and a low response rate does not
necessarily indicate non-response bias [18], with previ-
ous research showing similar results in early survey res-
ponders compared with those responding after intensive
contact attempts [19].
In conclusion, our findings suggest that to increase
the proportion of suspected RA patients being referred
within 3 days of presentation to primary care, there
needs to be a paradigm shift in GPs’ approaches to
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making referral decisions in patients with synovitis, mov-
ing away from the use of investigations to confirm their
clinical suspicion of RA and towards referring patients
based on clinical findings. Further research is required
to determine the best manner to implement this change
in referral practice and evaluate its impact on attaining
NICE quality standards.
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